A study from the Medicine, Karolinska Institutet, Sweden shows that “Increased Arterial Blood Pressure and Vascular Remodeling in Mice Lacking Salt-Inducible Kinase 1.” This study was published in the 02 January 2015 issue of Circulation Research by Prof. Laura Brion, Dr. Alejandro M Bertorello and others.
On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Molecular therapy for Hypertension: Gastrin decreases arterial blood pressure and vascular remodelling via up regulation of its target gene. Together, pharmacological formulations encompassing “Gastrin activators” may be used to decrease blood pressure.
Amount: $ 500
Undisclosed information: How Gastrin decreases arterial blood pressure and vascular remodelling
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, Molecular therapy for Hypertension: Gastrin decreases arterial blood pressure and vascular remodelling via up regulation of its target gene, 21/January/2014, 13.11, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation